Author:
Asano Michiyo,Umezu Tomohiro,Katagiri Seiichiro,Kobayashi Chiaki,Tauchi Tetsuzo,Gotoh Moritaka,Ando Keiko,Okabe Seiichi,Ohyashiki Junko H.,Ohyashiki Kazuma
Funder
JSPS KAKENHI grant
Private University Strategic Research-Based Support Project
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Mahon FX, Réa D, Guilho J, Guilhot F, Huguet F, Nicolini F, et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol. 2010;11:1029–35.
2. Richter J, Söderlund S, Lübking A, Dreimane A, Lotfi K, Markevärn B, et al. Musculoskeletal pain in patients with chronic myeloid leukemia after discontinuation of imatinib: a tyrosine kinase inhibitor withdrawal syndrome? J Clin Oncol. 2014;32:2821–3.
3. Ishii Y, Hagihara M, Kato A, Ando T, Itabashi M, Koyama S, et al. Musculoskeletal pain may be associated with imatinib withdrawal syndrome in chronic myeloid leukemia patients. Leuk Lymphoma. 2015. doi: 10.3109/10428194.2015.1064531 .
4. Lee SE, Choi SY, Song HY, Kim SH, Choi MY, Park JS, et al. Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study. Haematologica. 2016;101:717–23.
5. Katagiri S, Tauchi T, Saitoh Y, Suguro T, Asano M, Yoshizawa S, et al. Analysis of the musculoskeletal pain after tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia. Rinsho Ketsueki. 2016;57:873–6.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献